Harvard

Patients with long COVID can experience a constellation of debilitating neurological symptoms for months after infection, but the ‘underlying biology’ and a timeframe for these symptoms continue to elude clinicians, a presenter noted here.

More than 80% of therapies tested in phase 3 oncology trials did not demonstrate clinically meaningful benefit in extending survival, according to results of a study published in JNCCN — Journal of the National Comprehensive Cancer Network.

Dimethyl fumarate and fingolimod appeared to have no significant difference in relapse rates, and rituximab appeared to have better relapse outcomes than natalizumab in patients with MS, according to results published in JAMA Network Open.

New analyses from the REDUCE-IT study show icosapent ethyl significantly reduced total primary CV endpoints by 32% in patients with prior peripheral artery disease, suggesting substantial benefit for a high-risk population.

Approvals of BRAF-targeted therapies and immune checkpoint inhibitors have greatly expanded the melanoma treatment landscape during the past decade, according to a speaker at Chemotherapy Foundation Symposium.

An algorithm used in Fitbit wearable devices showed the capability to identify asymptomatic atrial fibrillation, according to results of the Fitbit Heart Study presented at the American Heart Association Scientific Sessions.

Higher sodium intake, measured in multiple 24-hour urine samples, was associated with greater risk for CVD in a dose-response manner, researchers reported at the American Heart Association Scientific Sessions.

Higher intake of vegetable fat, polyunsaturated fat and vegetable oil could reduce risk for stroke among healthy adults, whereas high intake of nondairy animal fat, total red meat and processed red meat may drive stroke risk, data show.

For years, adjuvant therapy for renal cell carcinoma was ‘under future direction’ in any research discussion.

Health care professionals must be advocates for reducing weight stigma by helping to develop policies and to eliminate weight discrimination in their clinics, according to a speaker at ObesityWeek 2021.